Disitamab vedotin (RC-48) is a HER2-targeting antibody-drug conjugate (ADC) that delivers the cytotoxic agent MMAE. It demonstrates potent anti-tumor activity in vitro and in vivo against gastric cancer models with varying HER2 expression, inhibiting proliferation and downregulating HER2 protein levels.
Konzentration:
20.6 mg/mL
Molekulargewicht:
Approximately 144.15 kDa
Reinheit:
98.00% (May vary between batches)
CAS Nummer:
[2136633-23-1]
Target-Kategorie:
EGFR,Antibody-Drug Conjugates (ADCs)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten